BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16113865)

  • 21. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
    Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
    Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Commercial methods for the diagnosis of CMV infection after organ or bone marrow transplantation].
    Schvoerer E; Stoll-Keller F
    Ann Biol Clin (Paris); 2002; 60(4):463-7. PubMed ID: 12147450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing serology, antigenemia assay and polymerase chain reaction for the diagnosis of cytomegalovirus infection in renal transplant patients.
    Bhatia J; Shah BV; Mehta AP; Deshmukh M; Sirsat RA; Rodrigues C
    J Assoc Physicians India; 2004 Apr; 52():297-300. PubMed ID: 15636331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients.
    Garrigue I; Boucher S; Couzi L; Caumont A; Dromer C; Neau-Cransac M; Tabrizi R; Schrive MH; Fleury H; Lafon ME
    J Clin Virol; 2006 May; 36(1):72-5. PubMed ID: 16481215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.
    Sanghavi SK; Abu-Elmagd K; Keightley MC; St George K; Lewandowski K; Boes SS; Bullotta A; Dare R; Lassak M; Husain S; Kwak EJ; Paterson DL; Rinaldo CR
    J Clin Virol; 2008 Aug; 42(4):335-42. PubMed ID: 18495527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of nested PCR and quantitative real time PCR for cytomegalovirus detection in renal transplant recipients.
    Kanaan A; Cour I; Alvarez-Lafuente R; Benedicto M; Culebras E; Prats D; Fernández C; Picazo JJ
    Int J Antimicrob Agents; 2004 Nov; 24(5):455-62. PubMed ID: 15519477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of cytomegalovirus in liver transplant biopsies. A comparison of light microscopy, immunohistochemistry, duplex PCR and nested PCR.
    Brainard JA; Greenson JK; Vesy CJ; Tesi RJ; Papp AC; Snyder PJ; Western L; Prior TW
    Transplantation; 1994 Jun; 57(12):1753-7. PubMed ID: 8016881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active CMV and EBV infections in renal transplant recipients with unexplained fever and elevated serum creatinine.
    Hasannia T; Moosavi Movahed SM; Vakili R; Rafatpanah H; Hekmat R; Valizadeh N; Rezaee SA
    Ren Fail; 2016 Oct; 38(9):1418-1424. PubMed ID: 27484706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of quantitative competitive polymerase chain reaction-enzyme-linked immunosorbent assay with LightCycler-based polymerase chain reaction for measuring cytomegalovirus DNA in patients after hematopoietic stem cell transplantation.
    Pumannova M; Roubalova K; Vitek A; Sajdova J
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):115-20. PubMed ID: 16406183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blinded, prospective study to define antigenemia and quantitative real-time polymerase chain reaction cutoffs to start preemptive therapy in low-risk, seropositive, renal transplanted recipients.
    David-Neto E; Triboni AH; Paula FJ; Vilas Boas LS; Machado CM; Agena F; Latif AZ; Alencar CS; Pierrotti LC; Nahas WC; Caiaffa-Filho HH; Pannuti CS
    Transplantation; 2014 Nov; 98(10):1077-81. PubMed ID: 24839894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients.
    Piiparinen H; Helanterä I; Lappalainen M; Suni J; Koskinen P; Grönhagen-Riska C; Lautenschlager I
    J Med Virol; 2005 Jul; 76(3):367-72. PubMed ID: 15902704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective study of the predictive value of polymerase chain reaction assay for cytomegalovirus in asymptomatic kidney transplant recipients.
    Benedetti E; Mihalov M; Asolati M; Kirby J; Dunn T; Raofi V; Fontaine M; Pollak R
    Clin Transplant; 1998 Oct; 12(5):391-5. PubMed ID: 9787946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of major leukocyte subpopulations for monitoring secondary cytomegalovirus infections in renal-allograft recipients by PCR.
    Schäfer P; Tenschert W; Cremaschi L; Gutensohn K; Laufs R
    J Clin Microbiol; 1998 Apr; 36(4):1008-14. PubMed ID: 9542927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of cytomegalovirus using PCR in serum from renal transplant recipients.
    Cunningham R; Harris A; Frankton A; Irving W
    J Clin Pathol; 1995 Jun; 48(6):575-7. PubMed ID: 7665705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of two quantitative real-time CMV-PCR tests calibrated against the 1st WHO international standard for viral load monitoring of renal transplant patients.
    Mannonen L; Loginov R; Helanterä I; Dumoulin A; Vilchez RA; Cobb B; Hirsch HH; Lautenschlager I
    J Med Virol; 2014 Apr; 86(4):576-84. PubMed ID: 24026892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients.
    Lehto JT; Lemström K; Halme M; Lappalainen M; Lommi J; Sipponen J; Harjula A; Tukiainen P; Koskinen PK
    Transpl Int; 2005 Dec; 18(12):1318-27. PubMed ID: 16297050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CMV antigenemia and quantitative viral load assessments in hematopoietic stem cell transplant recipients.
    Cardeñoso L; Pinsky BA; Lautenschlager I; Aslam S; Cobb B; Vilchez RA; Hirsch HH
    J Clin Virol; 2013 Feb; 56(2):108-12. PubMed ID: 23146665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients.
    Naumnik B; Małyszko J; Chyczewski L; Kovalchuk O; Małyszko J; Myśliwiec M
    Transplant Proc; 2007 Nov; 39(9):2748-50. PubMed ID: 18021976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring of human cytomegalovirus, HHV-6 and HHV-7 infection in kidney transplant recipients by molecular methods to predict HCMV disease after transplantation: a prospective study.
    Rayes N; Seehofer D; Lullius SG; Stein A; May G; Kahl A; Frei U; Neuhaus P; Meisel H
    Ann Transplant; 2005; 10(2):23-8. PubMed ID: 16218029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of real-time polymerase chain reaction and antigenemia assay to detect cytomegalovirus in pediatric transplants].
    Farfán U MJ; Torres T JP; Vergara A A; Donoso W G; Alba G A; Paris D C; Santolaya De P ME
    Rev Chilena Infectol; 2011 Apr; 28(2):113-7. PubMed ID: 21720689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.